홈 › 만성 폐쇄성 폐질환 › 텍사스

텍사스의 만성 폐쇄성 폐질환 임상 시험

만성 폐쇄성 폐질환 관련 연구 28개가 텍사스 내 여러 지역에서 참여자를 모집하고 있습니다.

텍사스의 도시

공식 연구 텍스트(영어)

A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)

GSK Investigational Site, Humble
GSK Investigational Site, Huntsville

피험자 모집 중3상

40세 ~ 80세 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07780669

A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis

Copd01 50001, Boerne
Copd01 50006, McKinney
Copd01 50005, Tomball

피험자 모집 중2상

40세 ~ 80세 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT07725939

Ensifentrine (MK-5884) Study for the Prevention of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in Adults With a History of Moderate or Severe Exacerbations While Receiving Standard of Care (SOC) (MK-5884-031/RPL554/ENHANCE-3)

Victoria Clinical Research Group ( Site 4430), Victoria

피험자 모집 중3상

40세 ~ 80세 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT07874815

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Premier Pulmonary Critical Care and Sleep, Denison
Baylor College of Medicine Medical Center, Houston
Prime Clinical Research - Lewisville, Lewisville

피험자 모집 중2상

40세 ~ 75세 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07759245

A Study to Investigate the Efficacy and Safety of Zelicapavir Compared With Placebo in Adults With RSV Who Are at High Risk for Severe Disease

PanAmerican Clinical Research - Brownville, Brownsville

피험자 모집 중2/3상

18세 이상 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT07908381

To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

Horizon Clinical Research Group., Cypress
Metroplex Pulmonary and Sleep Center, McKinney
DM Clinical Research - Tomball, Tomball

피험자 모집 중2상

40세 ~ 85세 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT07684820

A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)

GC2501 Study Site 109, Dallas

피험자 모집 중3상

18세 ~ 80세 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT07555483

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Research Site, Boerne
Research Site, Dallas
Research Site, Denison
외 5개

피험자 모집 중2상

40세 이상 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT07082738

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

Solace Clinical Research- Site Number : 8400087, Austin
IntraCare- Site Number : 8400034, Dallas
Premier Pulmonary Critical Care and Sleep- Site Number : 8400111, Denison
외 7개

피험자 모집 중3상

40세 ~ 80세 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT07190222

A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)

WB Contracted Clinical Research Site, McKinney
WB Contracted Clinical Research Site, Waxahachie

피험자 모집 중2상

40세 ~ 80세 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT07646587

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

South Texas Medical Research Institute, Inc., DBA TTS Research, Boerne
Ten20 Clinical Research, Carrollton
Horizon Clinical Research Group, Cypress
외 7개

피험자 모집 중2/3상

35세 ~ 80세 · 모든 성별 · 2026. 10. 22. 업데이트됨 · NCT07363694

A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

REX Clinical Trials - Beaumont- Site Number : 8400011, Beaumont

피험자 모집 중4상

40세 ~ 85세 · 모든 성별 · 2026. 10. 20. 업데이트됨 · NCT07053423

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

Houston Methodist/Primary Critical Care, Houston

피험자 모집 중

40세 ~ 84세 · 모든 성별 · 2026. 10. 19. 업데이트됨 · NCT06891755

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

Wellness Clinical Research - Allen- Site Number : 8400085, Allen
REX Clinical Trials - Beaumont- Site Number : 8400014, Beaumont
Novel Research - Bellaire- Site Number : 8400116, Bellaire
외 17개

피험자 모집 중3상

40세 ~ 80세 · 모든 성별 · 2026. 10. 19. 업데이트됨 · NCT07190209

STRIVE Post-Market Registry Study

Baylor Scott & White Research Institute, Dallas
University of Texas Southwestern, Dallas
University of Texas Health Science Center at Houston, Houston

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 10. 16. 업데이트됨 · NCT04302272

The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry

The Respire Institute, Houston
Activian Clinical Research, Kingwood
The Lung & Sleep Institute of North Texas, North Richland Hills

피험자 모집 중관찰 연구

40세 이상 · 모든 성별 · 2026. 10. 15. 업데이트됨 · NCT07612878

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

Research Site, Boerne
Research Site, El Paso
Research Site, Houston
외 6개

피험자 모집 중3상

40세 ~ 80세 · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT06878261

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

GSK Investigational Site, Austin
GSK Investigational Site, Dallas
GSK Investigational Site, El Paso
외 5개

피험자 모집 중3상

40세 ~ 80세 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT06961214

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation

GSK Investigational Site, Corsicana
GSK Investigational Site, Dallas
GSK Investigational Site, Houston
외 4개

피험자 모집 중3상

40세 ~ 80세 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT06959095

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Research Site, Abilene
Research Site, Brownsville
Research Site, Dallas
외 12개

피험자 모집 중3상

40세 ~ 80세 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06283966

An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema

University of Texas Southwestern, Dallas

피험자 모집 중

40세 ~ 80세 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT06035120

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

Baylor College of Medicine, Houston

피험자 모집 중2상

40세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT07059091

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

Research Site, Dallas
Research Site, Forney
Research Site, Fort Worth
외 5개

피험자 모집 중3상

40세 ~ 80세 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06883305

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

GSK Investigational Site, Dallas
GSK Investigational Site, DeSoto
GSK Investigational Site, Greenville
외 6개

피험자 모집 중3상

40세 ~ 75세 · 모든 성별 · 2026. 7. 28. 업데이트됨 · NCT07177339

Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

Liver Center of Texas, Dallas
Methodist Hospital, Richardson

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 7. 10. 업데이트됨 · NCT05181826

Interprofessional Pharmacogenomics (IPGx) Registry and Repository

Texas A&M Family Care, Bryan

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2025. 9. 12. 업데이트됨 · NCT06726590

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

Horizon Clinical Research Group, Houston
CHRISTUS Trinity Mother Frances Health System, Tyler

피험자 모집 중관찰 연구

50세 이상 · 모든 성별 · 2025. 8. 5. 업데이트됨 · NCT06122077

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

Respire Research Institute, Houston

피험자 모집 중

30세 이상 · 모든 성별 · 2025. 2. 6. 업데이트됨 · NCT05204888

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.